Von Hippel-Lindau Syndrome Phenotype With Prominent Vitreoretinal Neovascularization Treated With Early PPV: A Case Series and Literature Review.
Document Type
Article
Publication Date
2-1-2020
Publication Title
Ophthalmic Surgery, Lasers & Imaging Retina
Abstract
BACKGROUND AND OBJECTIVE: To describe a case series of three patients in one family with Von Hippel-Lindau (VHL) disease who presented with vitreoretinal neovascularization and resulting tractional retinal detachments (TRDs). This vitreoretinal phenotype of VHL may benefit from early surgical intervention.
PATIENTS AND METHODS: Descriptive case series of three patients in one family with VHL disease. A review of the literature regarding surgical intervention for VHL was performed.
RESULTS: All three patients developed prominent intravitreal neovascularization with fibrovascular growth within the vitreous secondary to a retinal capillary hemangioma. Two subjects with intravitreal neovascularization were treated with laser and cryotherapy but eventually developed a TRD. The final vision in these two patients was light perception and 20/300. The eye that was preemptively treated with vitrectomy to remove the vitreous sustaining the neovascularization had visual acuity of 20/50 after surgery.
CONCLUSION: Intravitreal neovascularization with fibrovascular proliferation may be an indication for vitrectomy prior to the development of retinal detachment. [Ophthalmic Surg Lasers Imaging Retina. 2020;51:109-115.].
Volume
51
Issue
2
First Page
109
Last Page
115
Recommended Citation
Zubair T, Callaway NF, Ludwig CA, Tang PH, Shields RA, Ji MH, Vail D, Powers MA, Moshfeghi DM. Von Hippel-Lindau Syndrome Phenotype With Prominent Vitreoretinal Neovascularization Treated With Early PPV: A Case Series and Literature Review. Ophthalmic Surg Lasers Imaging Retina. 2020 Feb 1;51(2):109-115. doi: 10.3928/23258160-20200129-07. PMID: 32084284.
DOI
10.3928/23258160-20200129-07
ISSN
2325-8179
PubMed ID
32084284